KZR – kezar life sciences, inc. (US:NASDAQ)
Stock Stats
News
Kezar Life Sciences GAAP EPS of -$1.53 beats by $0.42 [Seeking Alpha]
Kezar Life Sciences Reports Third Quarter 2025 Financial Results
Kezar Life Sciences Announces Presentation of PORTOLA Data at the American Association for the Study of Liver Disease (AASLD) – The Liver Meeting® 2025
Kezar Life Sciences (NASDAQ:KZR) was downgraded by analysts at TD Cowen from a "strong-buy" rating to a "strong sell" rating.
Kezar Life Sciences (NASDAQ:KZR) had its "market perform" rating reaffirmed by analysts at William Blair.
Form SCHEDULE 13G/A Kezar Life Sciences, Filed by: Avidity Partners Management LP
Form 10-Q Kezar Life Sciences, For: Sep 30
Form 8-K Kezar Life Sciences, For: Nov 12
Form 8-K Kezar Life Sciences, For: Nov 06
Form 8-K Kezar Life Sciences, For: Oct 20
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.